Blog

The Discovery on Target 2021 conference took place Sept 28-30 in Boston, bringing together several experts from across the US and globally to foster collaboration and share the latest advances in addressing key challenges in drug discovery. At this year’s…

Across the life sciences, researchers have contributed significantly to the response to COVID-19 — elucidating the pathogen, tracking the progression and consequences of infection, and uncovering many of the biological mechanisms associated with patients who display symptoms for months or…

We’re continuing our blog series, looking at the DNA of Codex DNA — our incredible employees and their stories. Team member: Izach Espiritu, Senior Field Service Engineer Came aboard: 2014 What do you do at Codex DNA? As a field…

Synthetic biology has become so important and widely used that it’s easy to forget how young the field is. Much of the innovation that we rely on today took place in just the last two decades. Codex DNA was originally…

Team member: Gary Mills, Director of Software Engineering What do you do at Codex DNA? I work on the BioXp™ system, both the 3200 and 3250. My team works on the software and scripting that run the protocols for the…

If you’re working with synthetic mRNA, we have exciting news to share. In addition to releasing a new workflow earlier this year that makes it possible to synthesize mRNA form pooled oligos in a single overnight run on our BioXp™…

Our BioXp™ automated end-to-end benchtop system has been used by scientists in many different focus areas to advance breakthroughs in protein engineering. We are delighted to share a great example of utilizing BioXp gene and clone workflows to build recombinant…

RNA Day is on Sunday, August 1st this year, and we welcome the international celebration of one of the most versatile biomolecules we have seen come to life. We have seen RNA play a key role in addressing the COVID-19…

Team member: Nate Maynard, Director of Biofoundry Services and Reagent Manufacturing What do you do at Codex DNA? I work closely with the manufacturing team to build the reagents that create DNA and RNA for the BioXp™ system. We also…

What work do you do at Codex DNA? I work with an amazing team that creates people processes for Codex DNA and facilitates the evolution of our company culture. This function is usually called Human Resources or HR, but we…

In his scientific career at Codex DNA, Krishna Kannan has led the development of new technologies for our BioXp™ system, allowing us to expand our services and meet customers’ demands. Krishna was also instrumental in bringing the BioXp small-scale mRNA…

We’re thrilled to announce the partnership with MBC Biolabs, a premier biotech incubator in the Bay Area. Under the terms of the collaboration, MBC Biolabs will leverage Codex DNA’s BioXp™ system to empower entrepreneurs in life sciences research with the…

In San Diego, scientists at ag biotech startup Cellibre are looking to replace traditional agriculture for producing high-value ingredients. One of their first targets is the highly valuable cannabinoid market, which they believe can be disrupted by producing natural, high-quality,…

Earlier this month, the Codex DNA team attended the RNA Society conference (all virtual in 2021) to discuss hot topics and relevant content for those responsible for leading their labs through the latest rounds of challenges and crossroads. A benefit…

Team member: Sarvagya Bhat, Electro-Mechanical Engineer What do you do at Codex DNA? I am part of the engineering division at Codex DNA, which is responsible for creating the next generation of products, as well as creating technology for the…

Earlier this month the Codex DNA team attended the PEGS Boston Summit, held this year as a virtual event. This important conference has been around for more than 15 years and is well known as a great resource to learn…

Scientists use automated DNA synthesis to identify regulatory mechanism in E. coli response to antimicrobial threats. Bacterial resistance to antibiotics is a looming public health crisis, and scientists continue to investigate how to better characterize the molecular mechanisms underpinning this…

Last week, we had the opportunity to partner with Jesse Erasmus, Acting Assistant Professor of the University of Washington School of Medicine and Director of Virology at HDT Bio, presenting a webinar titled Development of a replicon RNA vaccine platform…

BCC sits down with Jason Lehmann, PhD, from Codex DNA, Inc. in San Diego to talk about Codex DNA’s mission of applying breakthroughs in synthetic biology automation solutions. BCC podcast host Clara Mouawad and Jason talk about Codex DNA’s recent…

Synthetic biology has advanced rapidly through the years as biologists, physicists, and engineers have continued their efforts to deliver new solutions to global healthcare, agriculture, manufacturing, and environmental challenges. As rapidly as the field is evolving, it’s important to appreciate…

The global COVID-19 pandemic caused by the novel SARS-CoV-2 coronavirus created an urgent need for protective interventions. Fortunately, new advances in vaccine development — including nucleic acid-based approaches — have enabled the unprecedented rollout of multiple vaccine products within a…

We’re celebrating two of the biggest discoveries in scientific history: The molecular structure of DNA and the complete mapping of all genes in the human genome The discovery of DNA’s double helix in 1953 and the completion of the Human…

The bacterial scourge of the citrus greening disease has affected citrus production worldwide, causing tree decline and a serious threat to Florida’s citrus industry. Citrus greening disease, or Huanglongbing (HLB), is caused by Candidotus liberibacter (CLass) and is spread by…

Team member: Jared Pache, Director of Field Applications Came aboard: August 2019 What do you do at Codex DNA? My role is education, assisting our customers with their experimental design, providing applications support, and troubleshooting/technical support. I am involved in…

The quest for an effective vaccine against HIV has spanned decades. While the vaccine itself remains elusive, researchers are making important strides in figuring out how best to design and develop it. Recently, scientists from Duke University and NIH’s Vaccine…

The Codex DNA team loves to get its geek on. For the past year, we’ve missed in-person conferences, but virtual events still let us get up to speed on some of the latest advances in the scientific community. Most recently,…

The Codex DNA team was delighted to participate in this year’s SLAS annual conference, held by the Society for Laboratory Automation and Screening. While our favorite part of the virtual event was getting to interact with the many attendees who…

The In our DNA blog series profiles the terrific people who make Codex DNA a truly special place to work, as well as compelling science and technology success stories. Team member: Souriya Sengphet, Program and Solution Architecture Manager Came aboard:…

It can be tough to keep up on the latest COVID-19 news, but a new ebook from Biocompare is here to help. The ebook offers a nice array of articles focused on how novel tools are being used to accelerate…

Scientists have made a new discovery that could eventually lead to more effective treatment for malaria. In a series of experiments that included using the BioXp™ system, they determined that a key phospholipid and a related protein confer protection against…

Team member: Abraham Chen, Senior Customer Service Associate Came aboard: October 2020 What do you do at Codex DNA? In a retail setting, you imagine customer service as a call center or the smiling face behind a counter. However, in…

The next industrial revolution will be biological. By turning cells into factories, synthetic biology changes how we make everything from plastic to food to medicine. But achieving those goals will require overcoming the limitations of DNA design. This is still…

Monoclonal antibodies represent an important class of therapies for an ever-increasing number of diseases, infections, and health conditions. That’s why scientists around the world are working to improve the processes required to engineer new antibody candidates for therapeutic use. The…

Since the start of the COVID-19 pandemic, the Codex DNA team has been working hard to ensure that our customers have access to the tools they need to help in the fight against this public health scourge. We currently offer…

Today, in our ongoing employee profile series, we catch up with a member of our R&D team. Team member: Krishna Kannan, Staff Scientist Came aboard: November 2019 What do you do at Codex DNA? As part of the R&D team,…

As we are quickly approaching the end of 2020, we’re taking a moment to look back at the year — all 237 months of it. While we hope to never go through another year like this one, we can’t help…

At a recent Oxford Global NextGen Omics UK congress, our own Kirsty Maclean gave a presentation about how the BioXp™ system is powering advances in cell engineering. While she started with a high-level view of how synthetic biology applies to…

You probably know Codex DNA as the developer of the world’s first and only automated benchtop solution for generating gene fragments, clones, and libraries. While we’re incredibly proud of what we’ve accomplished so far, our mission goes well beyond streamlining…

There’s celebrating in the halls — and virtual halls — of Codex DNA. We are truly honored that our new BioXp™ 3250 system was selected as one of the year’s best innovations by The Scientist. This is a very prestigious…

One of the most popular applications of synthetic biology is to confer desired traits to an organism. Designing a range of possibilities and then testing each one for fitness, productivity, stability, or some other goal is critically important as the…

Back in 2013, I played a small role in response to what then seemed like the next potential pandemic — an outbreak of H7N9, an avian influenza virus. At the time, I was working with Novartis scientists, and we were…

If you were there for the early days of synthetic biology, you probably remember it the way we do: a relatively small number of academic scientists toiling in labs to build key parts, like toggle switches, and tinkering with the…

In the age of COVID-19, there has been a ton of scientific interest in nanobodies, or single-domain antibodies that can be used for finely targeted viral vaccines. It’s also been a hot topic among users of our BioXp™ system —…

Without question, the global outbreak of the novel coronavirus 2019 (SARS-CoV-2) that causes COVID-19 has dominated scientific discussion and has been fodder for a wealth of publications as the world urgently races for a better understanding of the mechanism of…

Breast cancer is now recognized as the most common malignancy worldwide among women, irrespective of age. Today’s standard of care and breast cancer management relies heavily on chemotherapy, hormone therapy, and targeted therapy. However, there is still much to be…

The Codex DNA team really enjoyed attending this year’s virtual Global Synthetic Biology Conference hosted by SynBioBeta. If you missed the event, we’ve got you covered — here’s our take on highlights from the meeting. BioXp™ system in the spotlight…

We’re continuing our blog series, looking at the DNA of Codex DNA — our incredible employees and their stories. Team member: Katie Lyons, Senior Scientist Came aboard: 2008 What do you do at Codex DNA? I develop and adapt biological…

For cancer patients with few other treatment options, the need for new targeted immunotherapies is genuinely a matter of life or death. So how to accelerate the development of new therapies? One key component is automated DNA synthesis. That was…

The treatment landscape for lymphoma – especially aggressive B-cell lymphomas — has been transformed by adoptive cellular immunotherapy with chimeric antigen receptor (CAR) T cells. Clinical trials with a focus on anti-CD19 CAR-T cell therapy have shown efficacy and long-term…

For BioXp™ system users, antibody drug discovery is one of the most popular applications. That’s why we were delighted to participate in the recent Oxford Global Biologics virtual conference, with a presentation from our own Kirsty Maclean, Director of Applications…

Several recent publications from the rockstar team at GigaGen illustrate how they are using the BioXp™ system to streamline antibody drug discovery workflows. It’s tough to overstate the importance of this area of research: monoclonal antibodies, antibody drug conjugates, and…

Today we’re excited to launch a blog series focused on our most valuable resource: our people. We wouldn’t be where we are today — enabling the tremendous science done by our customers — without the Codex DNA family. We’ll be…

Please join us in welcoming the newest member of the Codex DNA family. Like its BioXp™ 3200 predecessor, the BioXp™ 3250 system is a fully automated, benchtop platform for synthetic biology workflows — but this one reduces the timelines for…

When it comes to improving life, there is no science more exciting than synthetic biology. The more we learn from reading the DNA or RNA code of every organism on this planet, the better equipped we are to make significant…